CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) today announced that its commercial partner, ClearPoint Neuro, Inc (Nasdaq:CLPT), has initiated its full market release of the SmartFrame OR platform and ClearPoint Prism 3T Neuro Laser Therapy System, which is based on CLS’ technology, at the 2024 Biennial Meeting of the American Society of Stereotactic and Functional Neurosurgery taking place June 1-4 in Nashville. Through CLS commercial collaboration with ClearPoint Neuro in neurosurgery an integrated system is offered for MRI image-guided stereotactic laser ablation with